rocuronium bromide


Also found in: Wikipedia.

rocuronium bromide

a nondepolarizing neuromuscular blocking agent.
indication It is prescribed as an adjunct to general anesthesia in providing skeletal muscle relaxation.
contraindication It should not be given to patients with a known hypersensitivity to the product.
adverse effects The side effects most often reported include nausea, vomiting, respiratory problems, arrhythmias, hiccups, injection site edema, and rash.

rocuronium bromide

A non-DEPOLARIZING muscle relaxant drug used in general anaesthesia. A brand name is Esmeron.
Mentioned in ?
References in periodicals archive ?
Contract awarded for Rocuronium bromide 50 mg / 5 ml solution road, iv req 641
The US state of Virginia confirmed in response to a freedom of information request in July that it held stocks of Rocuronium Bromide, a Mylan-made drug that can be used to kill people.
To determine the efficacy of the neuromuscular blocking agent rocuronium bromide as a mydriatic agent in European kestrels (Falco tinnunculus) and to assess possible adverse effects due to its use, 10 kestrels received a single topical instillation with a pipette of 0.
A randomized controlled comparative study of rocuronium bromide versus succinylcholine for endotracheal intubation was undertaken to find out the efficacy of rocuronium bromide as a suitable substitute to succinlycholine.
a privately-held specialty pharmaceutical company, today announced two FDA approvals -- sumatriptan succinate injection and rocuronium bromide injection.
A novel concept of reversing neuromuscular block: chemical encapsulation of rocuronium bromide by a cyclodextrin-based synthetic host.
The pharmacokinetics and neuromuscular effects of rocuronium bromide in patients with liver disease.
anaphylaxis) to rocuronium bromide or other neuromuscular blocking agents.
The Company is in the process of submitting its application for approval of Rocuronium bromide, a next generation skeletal muscle relaxant that is also the first that can be stored at room temperature, to the Chinese Food and Drug Administration (SFDA).
A Proseal LMA size 4 was inserted under anaesthesia using fentanyl, propofol and rocuronium bromide.
OSS, The Netherlands, August 1 /PRNewswire/ -- Organon, the human healthcare business unit of Akzo Nobel (Euronext Amsterdam: AKZ), today announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved rocuronium bromide, its neuromuscular blocking agent (NMBA) for use during general anaesthesia, under the brand name Eslax(R).
a leading manufacturer of multi-source and branded injectable pharmaceutical products, today announced that it has launched Rocuronium Bromide Injection, the generic equivalent of Organon's Zemuron[R].